Gan fod digwyddedd a difrifoldeb COVID-19 yn isel ymhlith plant, ac oherwydd y materion diogelwch a gofnodwyd, nid yw JCVI ar hyn o bryd yn cynghori brechu pob plentyn a pherson ifanc arall sy'n iau na 18 oed fel mater o drefn. Rwyf yn ymwybodol y bu galw am frechu plant i'w hatal rhag cael syndrom COVID-19 ôl-acíwt (COVID hir).  Mae cyfraddau Covid ymhlith  plant yn gymharol isel ac mae gwybodaeth gyfyngedig o hyd am effeithiau uniongyrchol cyffredinol y feirws arnynt. Fodd bynnag, mae astudiaethau'n dod i'r amlwg sy'n dangos bod y risg hon yn isel iawn mewn plant, yn enwedig o’i gymharu ag oedolion, ac yn debyg i gymhlethdodau iechyd eilaidd heintiau feirysol anadlol eraill mewn plant. Mae fy swyddogion yn parhau i fod mewn cysylltiad agos â Choleg Brenhinol Pediatreg ac Iechyd Plant ar y mater hwn ac wedi sefydlu grŵp i ystyried effeithiau Covid Hir ar oedolion a phlant a chydlynu'r ymateb eang y mae ei angen. Mae'r grŵp yn cynnwys arweinwyr polisi plant yn ogystal â chydweithwyr clinigol ac ymchwil. Mae'r grŵp newydd ymrwymo i sefydlu is-grŵp, o dan gadeiryddiaeth Dr Mark Walker, i ystyried sefydlu llwybr gofal pediatrig i'w ddefnyddio gyda phlant â Covid Hir yng Nghymru.
As a result of the low incidence and severity of COVID-19 in children and the reported safety issues, the JCVI does not currently advise routine universal vaccination of all other children and young people less than 18 years of age. I am aware there have been calls for children to be vaccinated to prevent them getting post-acute COVID-19 syndrome (long COVID). COVID rates in children are relatively low and there is still limited information about the overall direct effects of the virus on them. However, studies are emerging which show that this risk is very low in children, especially in comparison with adults, and similar to the secondary health complications of other respiratory viral infections in children. My officials remain in close contact with the Royal College of Paediatrics and Child Health on this matter and have established a group to consider the impacts of Long COVID on both adults and children and co-ordinate the wide ranging response needed. The group includes children’s policy leads as well as clinical and research colleagues. The group has just committed to establishing a sub-group, chaired by Dr Mark Walker, to consider the establishment of a paediatric care pathway for use with children with Long COVID in Wales.